Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prairie Heart Institute (PHI) is a nationally recognized cardiovascular center headquartered in Springfield, Illinois, and is a specialized division of HSHS St. John's Hospital and the Hospital Sisters Health System (HSHS). The institute provides a comprehensive range of heart and vascular services, including advanced interventional cardiology, cardiac surgery, and electrophysiology. PHI is distinguished by its robust clinical research program, serving as a high-volume site for Phase II through Phase IV clinical trials for global pharmaceutical and medical device companies. Through its partnership with Prairie Cardiovascular Consultants, the institute operates a network of community-based clinics that bring specialized cardiac care to patients throughout central and southern Illinois. It is a regional leader in implementing cutting-edge technologies such as transcatheter aortic valve replacement (TAVR) and advanced rhythm management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HSHS St. John's Hospital Prairie Heart Institute.